Works matching DE "CYTOKINE release syndrome"
Results: 2425
Severe cases of local cytokine release syndrome (CRS); craniocervical edema soon after chimeric antigen T-cell (CAR-T) therapy.
- Published in:
- Oxford Medical Case Reports, 2025, v. 2025, n. 1, p. 1, doi. 10.1093/omcr/omae164
- By:
- Publication type:
- Article
Lack of HLH in FMF.
- Published in:
- Pediatric Rheumatology, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12969-025-01064-9
- By:
- Publication type:
- Article
Efficacy and safety of CAR-T cell therapy in B-ALL patients previously treated with blinatumomab.
- Published in:
- Blood Cancer Journal, 2025, v. 14, n. 1, p. 1, doi. 10.1038/s41408-025-01217-9
- By:
- Publication type:
- Article
Lipoxin A<sub>4</sub> levels correlate with severity in a Spanish COVID-19 cohort: potential use of endogenous pro-resolving mediators as biomarkers.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2024.1509188
- By:
- Publication type:
- Article
Adverse events in the nervous system associated with blinatumomab: a real-world study.
- Published in:
- BMC Medicine, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12916-025-03913-6
- By:
- Publication type:
- Article
Advancing Multiple Myeloma Immunotherapy: A Review of Chimeric Antigen Receptor T-Cell and Bispecific T-Cell Engagers Cell Therapies in Revolutionizing Treatment.
- Published in:
- Iranian Journal of Medical Sciences, 2025, v. 50, n. 1, p. 1, doi. 10.30476/ijms.2024.101739.3446
- By:
- Publication type:
- Article
Cardiovascular toxicity of tisagenlecleucel in children and adolescents: analysis of spontaneous reports submitted to FAERS.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1499143
- By:
- Publication type:
- Article
CAR-T buněčná terapie u systémových autoimunitních revmatických onemocnění.
- Published in:
- Czech Rheumatology / Česká Revmatologie, 2024, v. 32, n. 3, p. 94
- By:
- Publication type:
- Article
Assessment of Troponin Levels as a Biomarker of Myocardial Injury in Patients with Fatal Covid-19 for the Period 2020 to 2022: A Literature Review.
- Published in:
- Kufa Journal for Nursing Sciences, 2024, v. 14, n. 2, p. 41, doi. 10.36321/kjns.vi20242.16555
- By:
- Publication type:
- Article
Interleukin-6 related signaling pathways as the intersection between chronic diseases and sepsis.
- Published in:
- Molecular Medicine, 2025, v. 31, n. 1, p. 1, doi. 10.1186/s10020-025-01089-6
- By:
- Publication type:
- Article
Efficacy and safety of mosunetuzumab monotherapy for Japanese patients with relapsed/refractory follicular lymphoma: FLMOON-1.
- Published in:
- International Journal of Clinical Oncology, 2025, v. 30, n. 2, p. 389, doi. 10.1007/s10147-024-02662-5
- By:
- Publication type:
- Article
Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies.
- Published in:
- Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-56270-6
- By:
- Publication type:
- Article
EVALUATION OF COAGULATION PARAMETERS ACCORDING TO INFLAMMATION SEVERITY IN COVID-19 PATIENTS.
- Published in:
- 2020
- By:
- Publication type:
- Abstract
BD COVID-19 SOLUTIONS AND POC ANTIGEN TESTING.
- Published in:
- 2020
- By:
- Publication type:
- Abstract
IRON HOMEOSTASIS IN IMMUNE SYSTEM AND ITS IMPACT ON CYTOKINE STORM.
- Published in:
- Turkish Journal of Biochemistry / Turk Biyokimya Dergisi, 2020, v. 45, p. 18
- By:
- Publication type:
- Article
Utilization of donor CLL-1 CAR-T cells for the treatment of relapsed of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2024.1491341
- By:
- Publication type:
- Article
Mechanistic PKPD modeling to describe cytokine release associated with CD3 T-cell engager therapies.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2024.1463915
- By:
- Publication type:
- Article
Diabetes mellitus and Covid-19: the double trouble.
- Published in:
- Khyber Medical University Journal, 2024, v. 16, n. 4, p. 286
- By:
- Publication type:
- Article
Editorial: Immune studies of SARS-CoV2 and vaccines using preclinical modeling.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2024.1548624
- By:
- Publication type:
- Article
Effect of hemoperfusion in critically ill COVID-19 patients: a case series from a single-center hospital in Indonesia.
- Published in:
- Journal of Infection in Developing Countries, 2024, v. 18, p. S206, doi. 10.3855/jidc.19751
- By:
- Publication type:
- Article
Successful management of COVID‐19 and associated coagulopathy in a patient with durable left ventricular assist device.
- Published in:
- Journal of Cardiac Surgery, 2020, v. 35, n. 11, p. 3202, doi. 10.1111/jocs.14937
- By:
- Publication type:
- Article
Role of toll‐like receptors in modulation of cytokine storm signaling in SARS‐CoV‐2‐induced COVID‐19.
- Published in:
- Journal of Medical Virology, 2022, v. 94, n. 3, p. 869, doi. 10.1002/jmv.27405
- By:
- Publication type:
- Article
Modulation of Covid‐19 cytokine storm by tocilizumab.
- Published in:
- Journal of Medical Virology, 2022, v. 94, n. 3, p. 823, doi. 10.1002/jmv.27380
- By:
- Publication type:
- Article
Critical roles of cytokine storm and secondary bacterial infection in acute kidney injury development in COVID‐19: A multi‐center retrospective cohort study.
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 12, p. 6641, doi. 10.1002/jmv.27234
- By:
- Publication type:
- Article
Dexamethasone treatment may mitigate adverse effects of vitamin D deficiency in hospitalized Covid‐19 patients.
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 12, p. 6605, doi. 10.1002/jmv.27215
- By:
- Publication type:
- Article
Investigation of plasma exchange and hemoperfusion effects and complications for the treatment of patients with severe COVID‐19 (SARS‐CoV‐2) disease: A systematic scoping review.
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 10, p. 5742, doi. 10.1002/jmv.27182
- By:
- Publication type:
- Article
Cytokine storm in severe COVID‐19 pneumonia.
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 9, p. 5474, doi. 10.1002/jmv.27068
- By:
- Publication type:
- Article
Can molecular mimicry explain the cytokine storm of SARS‐CoV‐2?: An in silico approach.
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 9, p. 5350, doi. 10.1002/jmv.27040
- By:
- Publication type:
- Article
A case of COVID‐19, with cytokine storm, treated by consecutive use of therapeutic plasma exchange followed by convalescent plasma transfusion: A case report.
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 4, p. 1854, doi. 10.1002/jmv.26630
- By:
- Publication type:
- Article
Impact of disease‐modifying drugs on the severity of COVID‐19 infection in multiple sclerosis patients.
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 3, p. 1314, doi. 10.1002/jmv.26593
- By:
- Publication type:
- Article
Vitamin D status may indeed be a prognosticator for morbidity and mortality in patients with COVID‐19.
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 3, p. 1225, doi. 10.1002/jmv.26569
- By:
- Publication type:
- Article
Evaluation of 17 patients with COVID‐19 pneumonia treated with anakinra according to HScore, SOFA, MuLBSTA, and Brescia‐COVID respiratory severity scale (BCRSS) scoring systems.
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 3, p. 1532, doi. 10.1002/jmv.26473
- By:
- Publication type:
- Article
Late onset infectious complications and safety of tocilizumab in the management of COVID‐19.
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 3, p. 1459, doi. 10.1002/jmv.26429
- By:
- Publication type:
- Article
Comment on Hu et al: The cytokine storm and COVID‐19.
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 2, p. 631, doi. 10.1002/jmv.26396
- By:
- Publication type:
- Article
The association of interleukin‐6 value, interleukin inhibitors, and outcomes of patients with COVID‐19 in New York City.
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 1, p. 463, doi. 10.1002/jmv.26365
- By:
- Publication type:
- Article
COVID‐19: What type of cytokine storm are we dealing with?
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 1, p. 197, doi. 10.1002/jmv.26317
- By:
- Publication type:
- Article
Early use of tocilizumab in the prevention of adult respiratory failure in SARS‐CoV‐2 infections and the utilization of interleukin‐6 levels in the management.
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 1, p. 491, doi. 10.1002/jmv.26288
- By:
- Publication type:
- Article
The cytokine storm and COVID‐19.
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 1, p. 250, doi. 10.1002/jmv.26232
- By:
- Publication type:
- Article
Tocilizumab's efficacy in patients with Coronavirus Disease 2019 (COVID‐19) is determined by the presence of cytokine storm.
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 1, p. 120, doi. 10.1002/jmv.26209
- By:
- Publication type:
- Article
Encephalopathy in patients with COVID‐19: A review.
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 1, p. 206, doi. 10.1002/jmv.26207
- By:
- Publication type:
- Article
Could melatonin be used in COVID‐19 patients with laryngopharyngeal reflux disease?
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 1, p. 92, doi. 10.1002/jmv.26150
- By:
- Publication type:
- Article
Remdesivir and tocilizumab: Mix or match.
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 1, p. 56, doi. 10.1002/jmv.26117
- By:
- Publication type:
- Article
Tocilizumab in patients with severe COVID‐19: A single‐center observational analysis.
- Published in:
- Journal of Medical Virology, 2020, v. 92, n. 11, p. 2813, doi. 10.1002/jmv.26191
- By:
- Publication type:
- Article
Can steroids reverse the severe COVID‐19 induced "cytokine storm"?
- Published in:
- Journal of Medical Virology, 2020, v. 92, n. 11, p. 2866, doi. 10.1002/jmv.26165
- By:
- Publication type:
- Article
Higher levels of IL‐6 early after tocilizumab distinguish survivors from nonsurvivors in COVID‐19 pneumonia: A possible indication for deeper targeting of IL‐6.
- Published in:
- Journal of Medical Virology, 2020, v. 92, n. 11, p. 2852, doi. 10.1002/jmv.26149
- By:
- Publication type:
- Article
Gendered effects on inflammation reaction and outcome of COVID‐19 patients in Wuhan.
- Published in:
- Journal of Medical Virology, 2020, v. 92, n. 11, p. 2684, doi. 10.1002/jmv.26137
- By:
- Publication type:
- Article
Tocilizumab challenge: A series of cytokine storm therapy experiences in hospitalized COVID‐19 pneumonia patients.
- Published in:
- Journal of Medical Virology, 2020, v. 92, n. 11, p. 2648, doi. 10.1002/jmv.26111
- By:
- Publication type:
- Article
COVID‐19: Consider IL‐6 receptor antagonist for the therapy of cytokine storm syndrome in SARS‐CoV‐2 infected patients.
- Published in:
- Journal of Medical Virology, 2020, v. 92, n. 11, p. 2260, doi. 10.1002/jmv.26078
- By:
- Publication type:
- Article
COVID‐19 pneumonia treated with Sarilumab: A clinical series of eight patients.
- Published in:
- Journal of Medical Virology, 2020, v. 92, n. 11, p. 2368, doi. 10.1002/jmv.26062
- By:
- Publication type:
- Article
Clinical outcomes in COVID‐19 patients treated with tocilizumab: An individual patient data systematic review.
- Published in:
- Journal of Medical Virology, 2020, v. 92, n. 11, p. 2516, doi. 10.1002/jmv.26038
- By:
- Publication type:
- Article